Showing results (271-280 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|September 25, 2020
Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort studyShahinaz M Gadalla, Youjin Wang, Tao Wang, et al.
The Lancet. Haematology|December 8, 2020
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trialJacqueline Halton, Leonardo R Brandão, Matteo Luciani, et al.
The Lancet. Haematology|January 2, 2026
Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trialCharlotte L B M Korst, Wouter Plattel, Elizabeth A de Kort, et al.
The Lancet. Haematology|December 9, 2022
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMTNicola Polverelli, Juan Carlos Hernández-Boluda, Tomasz Czerw, et al.
The Lancet. Haematology|July 30, 2021
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trialTapan M Kadia, Patrick K Reville, Gautam Borthakur, et al.
The Lancet. Haematology|May 22, 2022
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trialFeng Xue, Huiyuan Li, Xia Wu, et al.
The Lancet. Haematology|January 29, 2021
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort studyLisa Pleyer, Michael Leisch, Alexandra Kourakli, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
The Lancet. Haematology|November 8, 2016
Association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal studyMary A M Rogers, Neil Blumberg, Steven J Bernstein, et al.
The Lancet. Haematology|December 9, 2016
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana LinfomiCarlo Visco, Annalisa Chiappella, Luca Nassi, et al.
Pageof 73